WEHI-345 analog
WEHI-345 analog is the analog of WEHI-345. WEHI-345 is a potent and selective RIPK2 kinase inhibitor with an IC50 of 0.13 μM, which delays RIPK2 ubiquitylation and NF-κB activation on oligomerization domain (NOD) stimulation[1].
Product Specifications
CAS Number
[1354825-62-9]
UNSPSC
12352005
Target
RIP kinase
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-Kinase/protease
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/WEHI-345-analog.html
Purity
98.41
Solubility
DMSO : 30 mg/mL (ultrasonic; warming)
Smiles
O=C(C1=NC=CC=C1C)NCC(C)(N2N=C(C3=CC=C(C)C=C3)C4=C(N)N=CN=C42)C
Molecular Formula
C23H25N7O
Molecular Weight
415.49
References & Citations
[1]Nachbur U, et al. A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine production. Nat Commun. 2015 Mar 17;6:6442.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
RIPK2
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![4,6-Dichloroimidazo[4,5-c]pyridine](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
LMO3 (LIM Domain only 3 (rhombotin-like 2), DAT1, MGC26081, RBTN3, RBTNL2, RHOM3, Rhom-3) (MaxLight 550)
